BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29082495)

  • 21. Prostate cancer cells increase androgen sensitivity by increase in nuclear androgen receptor and androgen receptor coactivators; a possible mechanism of hormone-resistance of prostate cancer cells.
    Fujimoto N; Miyamoto H; Mizokami A; Harada S; Nomura M; Ueta Y; Sasaguri T; Matsumoto T
    Cancer Invest; 2007 Feb; 25(1):32-7. PubMed ID: 17364555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PRMT2, a member of the protein arginine methyltransferase family, is a coactivator of the androgen receptor.
    Meyer R; Wolf SS; Obendorf M
    J Steroid Biochem Mol Biol; 2007 Oct; 107(1-2):1-14. PubMed ID: 17587566
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dynamics of intracellular movement and nucleocytoplasmic recycling of the ligand-activated androgen receptor in living cells.
    Tyagi RK; Lavrovsky Y; Ahn SC; Song CS; Chatterjee B; Roy AK
    Mol Endocrinol; 2000 Aug; 14(8):1162-74. PubMed ID: 10935541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth.
    Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R
    Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MOZ-TIF2 repression of nuclear receptor-mediated transcription requires multiple domains in MOZ and in the CID domain of TIF2.
    Yin H; Glass J; Blanchard KL
    Mol Cancer; 2007 Aug; 6():51. PubMed ID: 17697320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melanoma antigen gene protein-A11 (MAGE-11) F-box links the androgen receptor NH2-terminal transactivation domain to p160 coactivators.
    Askew EB; Bai S; Hnat AT; Minges JT; Wilson EM
    J Biol Chem; 2009 Dec; 284(50):34793-808. PubMed ID: 19828458
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The presence of both the amino- and carboxyl-terminal domains in the AR is essential for the completion of a transcriptionally active form with coactivators and intranuclear compartmentalization common to the steroid hormone receptors: a three-dimensional imaging study.
    Saitoh M; Takayanagi R; Goto K; Fukamizu A; Tomura A; Yanase T; Nawata H
    Mol Endocrinol; 2002 Apr; 16(4):694-706. PubMed ID: 11923466
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential expression of p160 steroid receptor coactivators in the rat testis and epididymis.
    Igarashi-Migitaka J; Takeshita A; Koibuchi N; Yamada S; Ohtani-Kaneko R; Hirata K
    Eur J Endocrinol; 2005 Oct; 153(4):595-604. PubMed ID: 16189181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulation of the transcriptional coactivator FHL2 licenses activation of the androgen receptor in castrate-resistant prostate cancer.
    McGrath MJ; Binge LC; Sriratana A; Wang H; Robinson PA; Pook D; Fedele CG; Brown S; Dyson JM; Cottle DL; Cowling BS; Niranjan B; Risbridger GP; Mitchell CA
    Cancer Res; 2013 Aug; 73(16):5066-79. PubMed ID: 23801747
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trafficking of androgen receptor mutants fused to green fluorescent protein: a new investigation of partial androgen insensitivity syndrome.
    Georget V; Térouanne B; Lumbroso S; Nicolas JC; Sultan C
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3597-603. PubMed ID: 9768671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis.
    Mulholland DJ; Read JT; Rennie PS; Cox ME; Nelson CC
    Oncogene; 2003 Aug; 22(36):5602-13. PubMed ID: 12944908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transcription intermediary factor 1β coactivates the androgen receptor.
    Van Tilborgh N; Spans L; Helsen C; Clinckemalie L; Dubois V; Lerut E; Boonen S; Vanderschueren D; Claessens F
    J Endocrinol Invest; 2013 Oct; 36(9):699-706. PubMed ID: 23563173
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantifying effects of ligands on androgen receptor nuclear translocation, intranuclear dynamics, and solubility.
    Marcelli M; Stenoien DL; Szafran AT; Simeoni S; Agoulnik IU; Weigel NL; Moran T; Mikic I; Price JH; Mancini MA
    J Cell Biochem; 2006 Jul; 98(4):770-88. PubMed ID: 16440331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions.
    Ghadessy FJ; Lim J; Abdullah AA; Panet-Raymond V; Choo CK; Lumbroso R; Tut TG; Gottlieb B; Pinsky L; Trifiro MA; Yong EL
    J Clin Invest; 1999 Jun; 103(11):1517-25. PubMed ID: 10359561
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A differential ligand-mediated response of green fluorescent protein-tagged androgen receptor in living prostate cancer and non-prostate cancer cell lines.
    Nakauchi H; Matsuda K; Ochiai I; Kawauchi A; Mizutani Y; Miki T; Kawata M
    J Histochem Cytochem; 2007 Jun; 55(6):535-44. PubMed ID: 17312014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trafficking of the androgen receptor in living cells with fused green fluorescent protein-androgen receptor.
    Georget V; Lobaccaro JM; Terouanne B; Mangeat P; Nicolas JC; Sultan C
    Mol Cell Endocrinol; 1997 Apr; 129(1):17-26. PubMed ID: 9175625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone stroma-derived cells change coregulators recruitment to androgen receptor and decrease cell proliferation in androgen-sensitive and castration-resistant prostate cancer cells.
    Villagran MA; Gutierrez-Castro FA; Pantoja DF; Alarcon JC; Fariña MA; Amigo RF; Muñoz-Godoy NA; Pinilla MG; Peña EA; Gonzalez-Chavarria I; Toledo JR; Rivas CI; Vera JC; McNerney EM; Onate SA
    Biochem Biophys Res Commun; 2015 Nov; 467(4):1039-45. PubMed ID: 26494300
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression, purification and crystallization of the ancestral androgen receptor-DHT complex.
    Colucci JK; Ortlund EA
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2013 Sep; 69(Pt 9):994-6. PubMed ID: 23989146
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-Throughput Screen for Inhibitors of Androgen Receptor-RUNX2 Transcriptional Regulation in Prostate Cancer.
    Vuong W; Tew BY; Little GH; Frenkel B; Jones JO
    J Pharmacol Exp Ther; 2016 Nov; 359(2):256-261. PubMed ID: 27554677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.